Related Experiment Videos

[Pulmonary nocardiosis in a patient who was a chronic corticosteroid user]

Renata Maria Ferreira Brasileiro1, André Carvalho Caribe de Araújo Pinho, Catarine Silva Medeiros

  • 1Serviço de Clínica Médica, Hospital Heliópolis, São Paulo, SP.

Insights

Pulmonary nocardiosis, a severe infection caused by Nocardia spp., can be fatal even with appropriate treatment. This case highlights the aggressive nature of Nocardia farcinica in immunocompromised patients.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Pulmonary nocardiosis is a rare but serious infection caused by Nocardia species.
  • Nocardia species can act as opportunistic or primary pathogens, leading to acute or chronic infections.

Observation:

  • A 49-year-old male patient with idiopathic thrombocytopenic purpura, undergoing corticosteroid therapy, developed a pulmonary infection.
  • Nocardia farcinica was identified as the causative agent, isolated from the patient's blood cultures.

Findings:

  • Despite receiving appropriate treatment with trimethoprim-sulfamethoxazole, the patient's condition did not improve.
  • The patient unfortunately succumbed to the infection three months after the initiation of antibiotic therapy.

Implications:

  • This case underscores the critical and potentially fatal nature of pulmonary nocardiosis, particularly in immunocompromised individuals.
  • It highlights the challenges in treating Nocardia farcinica infections and suggests a need for vigilance and potentially novel therapeutic strategies.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...